Schonfeld Strategic Advisors’s Core Laboratories CLB Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,600	Closed	-$350K	–	2188
2021 Q3	$350K	Buy	+12,600	New	+$384K	﹤0.01%	1445
2020 Q3	–	Sell	-11,300	Closed	-$230K	–	1392
2020 Q2	$230K	Sell	11,300 -3,300	-23%	-$59.2K	0.01%	1068
2020 Q1	$151K	Sell	14,600 -6,262	-30%	-$175K	0.01%	960
2019 Q4	$786K	Buy	+20,862	New	+$937K	0.02%	582
2019 Q3	–	Sell	-14,500	Closed	-$758K	–	1044
2019 Q2	$758K	Buy	+14,500	New	+$850K	0.03%	523
2018 Q2	–	Sell	-2,998	Closed	-$324K	–	785
2018 Q1	$324K	Buy	+2,998	New	+$332K	0.02%	576
2016 Q2	–	Sell	-2,072	Closed	-$233K	–	451
2016 Q1	$233K	Buy	+2,072	New	+$215K	0.1%	255

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Schonfeld Strategic Advisors's CLB Position: Q4 2021 in Review

Schonfeld Strategic Advisors sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 12,600 shares — an estimated $350K sold.

Schonfeld Strategic Advisors first reported a position in CLB in Q1 2016 and held it in 7 quarters. The position peaked at $786K in Q4 2019. 173 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

Schonfeld Strategic Advisors reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
Schonfeld Strategic Advisors sold 12,600 Core Laboratories shares in Q4 2021, an estimated $350K.
Schonfeld Strategic Advisors first reported a position in Core Laboratories in Q1 2016 and held it in 7 quarters.
Schonfeld Strategic Advisors's Core Laboratories position peaked at $786K in Q4 2019.
173 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.